5-[1'-(decahydro-7-hydroxy-1,1,3a,7-tetr amethyl1H-cyclopropa[a]naphtalen-4-yl)-3'- methylbutyl]-2,4,6-trihydroxy-1,3-benzenedicar boxaldehyde used as drugs

Details for Australian Patent Application No. 2009220011 (hide)

Owner Pierre Fabre Medicament

Inventors Fiorini-Puybaret, Christel; Joulia, Philippe

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009220011

PCT Pub. Number WO2009/106769

Priority 0800276 18.01.08 FR

Filing date 13 January 2009

Wipo publication date 3 September 2009

International Classifications

A23L 1/00 (2006.01) Foods or foodstuffs

A61K 31/11 (2006.01) - Aldehydes

A61K 36/61 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07C 47/57 (2006.01) Compounds having CHO groups

Event Publications

17 June 2010 PCT application entered the National Phase

  PCT publication WO2009/106769 Priority application(s): WO2009/106769

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009220013-Device for mounting an connecting sanitary equipment pipes provided being a wall and corresponding method

2009220004-System for attaching stretched walls or ceilings using a stringer having a reduced diameter